Skip to main content

News
Contact Us
|
International
United States
Canada

About Leadiant Biosciences
- Management Team
Research and Development
Products
Diseases
- CTX
- Hodgkin Disease

All Posts By

daniela.perri

Recent Posts

EMA grants Marketing Authorization for Chenodeoxycholic Acid Leadiant

Archives

April 2017

Leadiant Biosciences Ltd.
21 Holborn Viaduct
London
EC1A 2DY
UK

©2022 Leadiant Biosciences Ltd. / London, UK
GL-NP-2200012
Date of Production: July, 2022

About Leadiant Biosciences
- Management Team
Research and Development
Products
Diseases
- CTX
- Hodgkin Disease

Contact Us
Privacy Policy
Disclosure
Sitemap
Modern Slavery Act Statement (PDF)

Leadiant Biosciences, Inc. (U.S. and Canada)

About Leadiant Biosciences
- Management Team
Research and Development
Products
Diseases
- CTX
- Hodgkin Disease

News
Contact Us
|
International
United States
Canada

About Leadiant Biosciences
- Management Team
- Back
Research and Development
Products
Diseases
Contact Us
United States
Canada

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences Inc. Canada website. The information is intended for Canadian audiences only.

Continue Cancel

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences Inc. U.S. website. The information is intended only for residents of the United States.

Continue Cancel

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences S.p.A. (Corporate) website.

Continue Cancel